We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Sunday
May 08
14:15 - 15:15
Poster Station 2
14: Urology 2
Sofia Spampinato, The Netherlands
Poster Discussions are presented at one of the sessions scheduled at the two poster terminals in the exhibition. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be streamed but authors are invited to upload per-recordings for the online platform.
2460
Poster Discussion
Clinical
Determining interobserver variability in prostate bed CTV target delineation using MRI
Kobika Sritharan, United Kingdom
PD-0571
1.5T MR-guided RT versus linac-based VMAT SBRT in localized prostate cancer: a toxicity comparison
Luca Nicosia, Italy
PD-0574
Toxicity and QoL report of 1.5T MR-guided SBRT for prostate cancer in the first 100 patients
Luca Nicosia, Italy
PD-0575
Ultra-hypofractionated SBRT following radical prostatectomy: first results of a phase II trial
Angel Montero, Spain
PD-0576
Patient-reported acute urinary toxicity after daily adaptive MR-guided SBRT for prostate cancer
Thomas Willigenburg, The Netherlands
PD-0577
Ultra-hypo compared to moderate-hypo fractionated prostate IGRT with HDR brachytherapy boost.
Andre-Guy Martin, Canada
PD-0579
Offline-adaptive planning of mpMRI- and PSMA-PET- based dose escalation: results of a phase II trial
Simon KB Spohn, Germany
PD-0581
Phase II trial of SBRT for adrenal metastases: efficacy and impact on hormonal production.
Ciro Franzese, Italy
PD-0582
BELOW PRESENTATIONS AVAILABLE VIA ONLINE PLATFORM
Ten-year outcomes of post prostatectomy radiotherapy and external validation of an updated nomogram
Stephen Chin, Australia
PD-0572